Study: Black women get less breast cancer treatment

Here's more data suggesting that big ethnic care gaps still exist. A newly-published study has concluded that black women with breast cancer that has spread to the lymph nodes are less likely to be offered add-on therapies like chemotherapy or tamoxifen treatment than similarly-ill white women.

The study, which will be published in November in the journal Cancer, looked at data on 630 women diagnosed with breast cancer at the Karmanos Cancer Institute in Detroit between 1990 and 1996. Of that group, 388 patients were black and 242 were white. Researchers concluded that white women whose cancer had spread to the nodes were a startling five times more likely as blacks to take cancer-preventing drug tamoxifen, and three times more likely to get chemotherapy.

To find out more about the study:
- read this HealthDay News item

Related Articles:
Dialysis firms defend anemia drug use along ethnic lines. Report
Groups work for single, shared quality standard. Report
Too few patients get clot-busting drugs. Report
Study: CA death rates vary by race. Report
Medical homes cut racial care disparities. Report
Racial disparities persist in health outcomes. Report
Medicare should help fix disparities. Report
Researchers fight for ethnic diversity in trials. Report
San Francisco tracks biggest killers of its ethnic groups. Article

Suggested Articles

The profit margins and management of Community Health Group raise questions about oversight of managed care insurers.

Financial experts are warning practices about the pitfalls of promoting medical credit cards to their patients.

A proposed rule issued by HHS on Tuesday would expand short-term coverage, a move Seema Verma said will have "virtually no impact" on ACA premiums.